Caspofungin Study for Fungal Infections in Adults in Critical Care Settings

Summary

Adults admitted to intensive care units are at risk for a variety of complications. One of the most frequent complications is the development of new infections. Infections due to a fungus called Candida are of particular concern. This study will test the possibility that caspofungin, a new therapy for fungal infections, may reduce the rate of Candida infections in subjects at risk.

Timeline

Start

2004-10

Primary completion

—

Completion

2006-09

Drugs

Indications